Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin. | Leukemia;16(5): 820-5, 2002 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.

Styczynski, J; Wysocki, M; Balwierz, W; Kowalczyk, J R.

Affiliation

Styczynski J; Department of Pediatric Hematology and Oncology, Medical University, ul. Gersona 17-8, 85-305 Bydgoszcz, Poland.

Leukemia ; 16(5): 820-5, 2002 May.

Article in En | MEDLINE | ID: mdl-11986942

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Razoxane / Leukemia / Daunorubicin / Drug Resistance, Neoplasm / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Razoxane / Leukemia / Daunorubicin / Drug Resistance, Neoplasm / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication: